Related Experiment Video
Updated: Jan 19, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p
1Department of Central Laboratory, the Rizhao People's Hospital Affiliated to Jining Medical University, Rizhao, Shandong, China. wgprzph93@126.com.
Objective:
Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer. Long noncoding RNAs (lncRNAs) have been reported to be involved in the development of TNBC. However, the role and mechanism of LINC01096 in TNBC are largely unclear. This work aims to investigate the effect of LINC01096 on cell viability, apoptosis, migration, and invasion of TNBC cells, as well as explore the interaction between LINC01096 and microRNA (miR)-3130-3p.
Patients And Methods:
Sixty TNBC patients were recruited. T47-D and BT-549 cells were cultured for experiments in vitro. The expression levels of LINC01096 and miR-3130-3p were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Cell viability, apoptosis, migration, and invasion were determined by MTT, flow cytometry, and trans-well assays. The target association between LINC01096 and miR-3130-3p was confirmed by the luciferase reporter assay.
Results:
The expression of LINC01096 was enhanced in TNBC tissues and cells. High expression of LINC01096 predicted poor outcomes of patients with TNBC. Silence of LINC01096 led to the suppression of cell viability, migration, and invasion, as well as the promotion of apoptosis in TNBC cells. MiR-3130-3p was targeted by LINC01096 and lowly expressed in TNBC. Overexpression of miR-3130-3p repressed cell viability, migration, and invasion, while it induced apoptosis. However, the knockdown of miR-3130-3p induced the opposite effect. This was weakened by inhibiting LINC01096.
Conclusions:
Knockdown of LINC01096 inhibited cell viability, migration, and invasion; however, it promoted apoptosis in TNBC by up-regulating miR-3130-3p, indicating a novel target for the treatment of TNBC.
Insights
Reducing LINC01096 levels inhibits triple-negative breast cancer (TNBC) progression and promotes apoptosis. This suggests LINC01096 is a potential therapeutic target for TNBC by modulating miR-3130-3p.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited targeted therapies.
- Long noncoding RNAs (lncRNAs) play emerging roles in TNBC development and progression.
- The specific function and mechanism of LINC01096 in TNBC remain largely uncharacterized.
Purpose of the Study:
- To investigate the role of LINC01096 in TNBC cell behavior, including viability, apoptosis, migration, and invasion.
- To elucidate the underlying mechanism of LINC01096 action in TNBC.
- To explore the interaction between LINC01096 and microRNA (miR)-3130-3p in TNBC.
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to assess LINC01096 and miR-3130-3p expression in 60 TNBC patients and cell lines (T47-D, BT-549).
- In vitro assays including MTT, flow cytometry, and trans-well assays to evaluate cell viability, apoptosis, migration, and invasion.
- Luciferase reporter assay to confirm the direct targeting relationship between LINC01096 and miR-3130-3p.
Main Results:
- LINC01096 expression was significantly upregulated in TNBC tissues and cells, correlating with poor patient outcomes.
- Silencing LINC01096 suppressed TNBC cell viability, migration, and invasion, while inducing apoptosis.
- LINC01096 directly targets and downregulates miR-3130-3p, which itself exhibits tumor-suppressive functions in TNBC.
Conclusions:
- LINC01096 knockdown inhibits TNBC cell viability, migration, and invasion by upregulating miR-3130-3p.
- This study identifies a novel regulatory axis (LINC01096/miR-3130-3p) with therapeutic implications for TNBC.
- LINC01096 represents a potential novel therapeutic target for the treatment of triple-negative breast cancer.
Related Concept Videos
MicroRNAs
MicroRNAs

